Insider transactions

EDGAR

ASP Isotopes Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
2 transactions, 23,000 shares
Sum of shares × price per share: 61,800
Open-market sales (code S)
28 transactions, 1,444,006 shares
Sum of shares × price per share: 8,176,008.533

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–39 of 39

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-16 Filed 2026-10-21Kiessling Heather Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)21,8302.19
47,807.7

Derived: shares × price per share. Exact value 47807.70.

1,504,422Direct (D) No
F1
  • F1 Represents shares automatically sold by ASP Isotopes Inc.(the Company) on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations. The sale does not represent a discretionary trade by the reporting person.
Open filing 0001477932-26-006387 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Ainscow Robert Officer: COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)22,5002.114
47,565

Derived: shares × price per share. Exact value 47565.000.

2,225,941Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 2.05 to $2.22, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-006312 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-01Ryan Robert John Andrew Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)15,0002.68
40,200

Derived: shares × price per share. Exact value 40200.00.

675,222Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.65 to $2.68, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-005964 Read from the filing’s XML Dispute this row
2026-09-28 Filed 2026-09-30Ryan Robert John Andrew Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)8,0002.7
21,600

Derived: shares × price per share. Exact value 21600.0.

660,222Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.56 to $2.79, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-005918 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-10Ainscow Robert Officer: COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,4384.292
36,215.896

Derived: shares × price per share. Exact value 36215.896.

2,248,441Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.185 to $4.39, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-005524 Read from the filing’s XML Dispute this row
2026-09-04 Filed 2026-09-04Mann Paul Elliot Director · Officer: Chairman and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)83,7594.10
343,411.9

Derived: shares × price per share. Exact value 343411.90.

9,328,570Direct (D) Yes
F1, F4
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.925 to $4.26, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-005430 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Mann Paul Elliot Director · Officer: Chairman and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)83,7583.92
328,331.36

Derived: shares × price per share. Exact value 328331.36.

9,412,329Direct (D) Yes
F1, F3
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.875 to $3.98, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-005430 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Ainscow Donald George Officer: EVP, Gen Counsel, Secretary
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)23,6783.89
92,107.42

Derived: shares × price per share. Exact value 92107.42.

776,322Direct (D) No
F1, F2
  • F1 Represents shares automatically sold by ASP Isotopes Inc. (the Company) on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations. The sale does not represent a discretionary trade by the reporting person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.885 to $3.9202, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-005432 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Mann Paul Elliot Director · Officer: Chairman and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)83,7583.91
327,493.78

Derived: shares × price per share. Exact value 327493.78.

9,496,087Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.96, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-005430 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Ainscow Robert Officer: COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,0003.905
97,625

Derived: shares × price per share. Exact value 97625.000.

2,256,879Direct (D) Yes
F1, F2
  • F1 Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 13, 2024.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.96, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-005431 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Kiessling Heather Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)23,1246.28
145,218.72

Derived: shares × price per share. Exact value 145218.72.

1,526,252Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 19, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.13 to $6.52, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-004177 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Ainscow Donald George Officer: EVP, Gen Counsel, Secretary
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)100,0006.14
614,000

Derived: shares × price per share. Exact value 614000.00.

800,000Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.11 to $6.17, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-004176 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01Wider Todd Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)50,0006.12
306,000

Derived: shares × price per share. Exact value 306000.00.

672,247Direct (D) No
F2
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.10 to $6.25, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-004157 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01Gorley Michael Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)30,0006.27
188,100

Derived: shares × price per share. Exact value 188100.00.

87,908Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.10 to $6.63, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-004156 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Wider Todd Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)50,0006.25
312,500

Derived: shares × price per share. Exact value 312500.00.

722,247Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.21 to $6.31, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-004157 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-10Ainscow Robert Officer: COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,4386.999
59,057.562

Derived: shares × price per share. Exact value 59057.562.

2,281,879Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.785 to $7.265, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-003753 Read from the filing’s XML Dispute this row
2026-06-03 Filed 2026-06-03Mann Paul Elliot Director · Officer: Chairman and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)83,7597.76
649,969.84

Derived: shares × price per share. Exact value 649969.84.

9,579,845Direct (D) Yes
F2, F5
  • F2 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
  • F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.53 to $8.13, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-003633 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-03Mann Paul Elliot Director · Officer: Chairman and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)83,7588.29
694,353.82

Derived: shares × price per share. Exact value 694353.82.

9,663,424Direct (D) Yes
F2, F4
  • F2 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.81 to $8.52, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-003633 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Mann Paul Elliot Director · Officer: Chairman and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)83,7587.88
660,013.04

Derived: shares × price per share. Exact value 660013.04.

9,747,182Direct (D) Yes
F2, F3
  • F2 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $8.14, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open filing 0001477932-26-003633 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-03Kiessling Heather Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)840,000——1,549,376Direct (D) No
F1
  • F1 This award of common stock shall vest (subject to compliance with applicable vesting conditions) in semi-annual installments over a four-year period beginning on the grant date.
Open filing 0001477932-26-003630 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-03Ainscow Donald George Officer: EVP, Gen Counsel, Secretary
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)400,000——900,000Direct (D) No
F1
  • F1 This award of common stock shall vest (subject to compliance with applicable vesting conditions) in semi-annual installments over a four-year period beginning on the grant date.
Open filing 0001477932-26-003631 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-03Mann Paul Elliot Director · Officer: Chairman and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,233,555——9,830,940Direct (D) Yes
F1
  • F1 This award of common stock was issued to the reporting person pursuant to his Employment Agreement dated October 4, 2021, as amended on December 20, 2022 and April 5, 2024, and shall vest (subject to compliance with applicable vesting conditions) in four equal installments over a one-year period beginning on March 1, 2026.
Open filing 0001477932-26-003633 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-03Ainscow Robert Officer: Chief Operating Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)800,000——2,290,317Direct (D) No
F1
  • F1 This award of common stock shall vest (subject to compliance with applicable vesting conditions) in semi-annual installments over a four-year period beginning on the grant date.
Open filing 0001477932-26-003632 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-17Ainscow Robert Officer: COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)22,5005.205
117,112.5

Derived: shares × price per share. Exact value 117112.500.

1,490,317Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.055 to $5.52, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-002390 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-17Moore Duncan Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)11,6425.205
60,596.61

Derived: shares × price per share. Exact value 60596.610.

1,044,928Direct (D) Yes
F3, F4
  • F3 The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 31, 2025 and includes an amount for the purpose of satisfying the reporting person's income tax liabilities resulting from the vesting of a previously granted restricted stock award pursuant to an issuer equity incentive plan.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.055 to $5.52, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-002387 Read from the filing’s XML Dispute this row
2026-04-15 Filed 2026-04-17Kiessling Heather Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)23,1245.478
126,673.272

Derived: shares × price per share. Exact value 126673.272.

709,376Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 19, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.12 to $5.71, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-002388 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-04-13Ainscow Robert Officer: COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,0004.511
112,775

Derived: shares × price per share. Exact value 112775.000.

1,512,817Direct (D) Yes
F1, F2
  • F1 Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 13, 2024.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.42 to $4.58, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-002188 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-06Ainscow Robert Officer: COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,4385.439
45,894.282

Derived: shares × price per share. Exact value 45894.282.

1,537,817Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.65, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-001231 Read from the filing’s XML Dispute this row
2026-03-02 Filed 2026-03-02Mann Paul Elliot Officer: Executive Chairman
S

Open market or private sale of non-derivative or derivative security

Common Stock
Acquired (A)162,1535.436
881,463.708

Derived: shares × price per share. Exact value 881463.708.

7,597,385Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.57, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-26-001127 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2026-04-17Moore Duncan Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)36,548——1,056,570Direct (D) Yes
F2
  • F2 2025 annual award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc.
Open filing 0001477932-26-002387 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-29Kiessling Heather Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)80,0005.798
463,840

Derived: shares × price per share. Exact value 463840.000.

732,500Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.73 to $5.885, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.
Open filing 0001477932-25-009230 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Gorley Michael Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)36,548——117,908Direct (D) No
F1
  • F1 Annual award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc
Open filing 0001477932-25-009164 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Hunter Ralph L. JR Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)36,548——47,018Direct (D) No
F1
  • F1 Annual award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc.
Open filing 0001477932-25-009167 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Wider Todd Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)36,548——772,247Direct (D) No
F1
  • F1 Annual award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc.
Open filing 0001477932-25-009171 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Ryan Robert John Andrew Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)36,548——652,222Direct (D) No
F1
  • F1 Annual award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc.
Open filing 0001477932-25-009169 Read from the filing’s XML Dispute this row
2025-12-08 Filed 2025-12-11Ainscow Robert Officer: Interim CEO and COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,4386.203
52,340.914

Derived: shares × price per share. Exact value 52340.914.

1,546,255Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.03 to $6.525, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-25-008938 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-03Mann Paul Elliot Director · Officer: Executive Chairman
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)162,1535.753
932,866.209

Derived: shares × price per share. Exact value 932866.209.

7,759,538Direct (D) Yes
F1, F2
  • F1 Represents sell to cover sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.565 to $5.9565, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-25-008769 Read from the filing’s XML Dispute this row
2025-11-25 Filed 2025-11-28Ainscow Robert Officer: Interim CEO and COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,0005.769
144,225

Derived: shares × price per share. Exact value 144225.000.

1,554,693Direct (D) Yes
F1, F2
  • F1 Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 13, 2024.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.54 to $6.015, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-25-008682 Read from the filing’s XML Dispute this row
2025-11-25 Filed 2025-11-28Mann Paul Elliot Director · Officer: Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)50,0005.769
288,450

Derived: shares × price per share. Exact value 288450.000.

7,921,691Direct (D) Yes
F3, F4
  • F3 Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 13, 2024.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.54 to $6.015, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the Company), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Open filing 0001477932-25-008681 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Encompass Capital Advisors LLC Common Stock, par value $0.0100.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005363 Dispute this row
Todd J. Kantor Common Stock, par value $0.010.000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005363 Dispute this row
AK Jensen Investment Management Ltd Common stock, par value $0.01 per share4.87,417,144.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001962663-26-000002 Dispute this row
BlackRock, Inc. Common Stock6.68,274,76303/31/2026 Filed 2026-04-27SCHEDULE 13G/AAmendment 1Open filing 0002012383-26-001668 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 1Open filing 0000102909-26-000704 Dispute this row
Encompass Capital Advisors LLC Common Stock, par value $0.015.136,413,362.0001/16/2026 Filed 2026-01-23SCHEDULE 13GOpen filing 0001172661-26-000290 Dispute this row
Todd J. Kantor Common Stock, par value $0.015.136,413,362.0001/16/2026 Filed 2026-01-23SCHEDULE 13GOpen filing 0001172661-26-000290 Dispute this row
Mann Paul Elliot Common Stock, $0.01 par value7.07,759,53812/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 3Open filing 0001477932-26-000870 Dispute this row
BNP Paribas Asset Management UK Ltd Common Stock0.9944,326.0012/31/2025 Filed 2026-02-09SCHEDULE 13G/AAmendment 1Open filing 0001389277-26-000005 Dispute this row
The Vanguard Group Common Stock5.776,406,24412/31/2025 Filed 2026-01-30SCHEDULE 13GOpen filing 0000102909-26-000082 Dispute this row
AK Jensen Investment Management Ltd Common stock, par value $0.01 per share5.44,955,261.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 3Open filing 0001962663-25-000004 Dispute this row
AWM Investment Company, Inc. Common Stock4.33,931,186.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001535264-25-000048 Dispute this row
AWM Investment Company, Inc. Common Stock6.9619,874.0006/30/2025 Filed 2025-08-14SCHEDULE 13GOpen filing 0001535264-25-000047 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,477,433 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,836
2016222,374
2017207,870
2018222,268
2019215,153
2020166,955
2021249,834
2022187,707
2023229,670
2024233,862
2025235,520
2026260,174

Filings made before the SEC required XML are listed, not extracted.

Back to ASP Isotopes Inc.